Heart Failure Clinical Trial

Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Summary

Prospective, randomized, open-label, international, multi-center clinical study to evaluate the safety and efficacy of the AccuCinch Ventricular Restoration System in patients with heart failure and reduced ejection fraction (HFrEF).

View Full Description

Full Description

The CORCINCH-HF Study is a prospective, randomized, open-label, multicenter, international, clinical safety and efficacy investigation of the AccuCinch Ventricular Restoration System.

Subjects will be randomized in a 1:1 ratio:

Treatment group: AccuCinch Ventricular Restoration System plus guideline-directed medical therapy (GDMT) (n~200)
Control group: Guideline-directed medical therapy (GDMT) (n~200)

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age 18-years or older
Ejection Fraction: ≥20% and ≤40% measured by transthoracic echocardiography (TTE) and assessed by an echocardiography (echo) core lab
LV end-diastolic diameter ≥55 mm measured by TTE and assessed by an echo core lab

Symptom Status:

NYHA III,
NYHA ambulatory IV, or
NYHA II with a heart failure hospitalization within the prior 12 months (of signing the consent)
Able to complete six-minute walk test with distance between 100 m and 450 m.

Diagnosis and treatment for heart failure should be established at least 90 days before the date of consent. Subjects should be on stable, optimally titrated medical therapy for at least 30 days, as recommended according to current guidelines as standard-of-care for Heart Failure therapy, with any intolerance documented.

"Stable" is defined as no more than a 100% increase or a 50% decrease of total daily doses. Medication changes within this range do not require any additional waiting before the screening assessments
When a total daily dose increase or decrease exceeds that which is considered stable, the screening TTE and CT will be postponed 30 days after the medication change
When additional titration is required to optimize a subject's medication that exceeds what is considered stable, the screening TTE and CT will be postponed at least 30 days after achieving the optimal dose (provided the optimal dose remains outside of the stable parameters)
When a dose-for-dose equivalent change in the class of medication change is made, no additional waiting is required before the screening assessments
When a change in class medication change exceeds what is considered stable, OR a new class of medication is added, the screening TTE and CT will be postponed 30 days after the medication change
If an SGLT2 inhibitor is added to a subject's medications, the screening TTE and CT will be postponed at least 30 days after the addition
If an SGLT2 inhibitor dose changes per the stable definition above, no additional waiting is required before the screening assessments
If an SGLT2 inhibitor dose change exceeds what is considered stable, the screening TTE and CT will be postponed at least 30 days after achieving the optimal dose (provided the dose remains outside of the stable parameters)
When applicable, for guideline-directed device-based therapies: a CRT device must be placed > 90 days before the screening TTE and CT, and an ICD must be placed > 30 days before the screening TTE and CT
Able and willing to complete all qualifying diagnostic and functional tests, willing to accept blood product transfusion if required and agrees to comply with study follow-up schedule

Exclusion Criteria:

Cardiovascular

Myocardial infarction or any percutaneous cardiovascular intervention, cardiovascular surgery, or carotid surgery within 90 days prior to consent
Untreated clinically significant coronary artery disease (CAD) requiring revascularization
Fluoroscopic or echocardiographic evidence of severe aortic arch calcification, mobile aortic atheroma, intracardiac mass, thrombus or vegetation
Suboptimal ventricular anatomy or wall thickness as determined from screening echocardiography and/or CT scan
Heart failure on the basis other than ischemic or non-ischemic dilated cardiomyopathy (e.g., hypertrophic cardiomyopathy, amyloid cardiomyopathy, restrictive cardiomyopathy, uncorrected congenital heart disease, constrictive pericarditis)
Hemodynamic instability within 30 days prior to the implant defined as subject requiring inotropic support or mechanical hemodynamic support
Any planned cardiac surgery or interventions within the next 180 days post-randomization (including therapeutic right heart procedures)
Active bacterial endocarditis
Severe RV dysfunction assessed by right heart catheterization (RHC) and/or TTE
Fixed pulmonary hypertension with PA systolic pressure >70 mmHg not responsive to vasodilator therapy

History of any stroke within the prior 90 days of consent or documented Modified Rankin Scale ≥ 2 disability from any prior stroke

Valvular

Mitral regurgitation grade 3+ (moderate-severe) or 4+ (severe)
Untreated degenerative (primary) mitral valve disease (mild prolapse with no need for intervention is allowable)
Prior mitral or aortic valve replacement
Tricuspid regurgitation grade 4+ (severe)
Moderate or severe aortic valve stenosis (AVA less than 1.5 cm2 or peak velocity AV Vmax >300 cm/sec)

Aortic regurgitation grade 2+ (moderate), 3+ (moderate-severe), or 4+ (severe)

Procedural

Anatomical pathology or constraints preventing appropriate access/implant of the AccuCinch Ventricular Restoration System (e.g., femoral arteries will not support a 20F Introducer sheath)
Renal insufficiency (i.e., eGFR of <25 ml/min/1.73 m2)
Subjects in whom anticoagulation during the procedure is contraindicated
Subjects in whom 90 days of antiplatelet therapy is contraindicated
Known allergy to nitinol, polyester, or polyethylene

Any prior true anaphylactic reaction to contrast agents; defined as known anaphylactoid or other non-anaphylactic allergic reactions to contrast agents that cannot be adequately pre-medicated prior to the index procedure

General

Life expectancy <1 year due to non-cardiac conditions
Currently participating in another interventional investigational study
Subjects on high dose steroids or immunosuppressant therapy
Female subjects who are pregnant, of child-bearing potential without a documented birth control method, or who are lactating

Study is for people with:

Heart Failure

Estimated Enrollment:

400

Study ID:

NCT04331769

Recruitment Status:

Recruiting

Sponsor:

Ancora Heart, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 104 Locations for this study

See Locations Near You

Grandview Medical Group Research, LLC
Birmingham Alabama, 35243, United States More Info
Susan Thorington, RN
Contact
205-971-7578
[email protected]
Juan Bernal, MD
Principal Investigator
University of Alabama at Birmingham
Birmingham Alabama, 35294, United States
Phoenix Cardiovascular Research Group
Phoenix Arizona, 85016, United States More Info
Jessica Byrne
Contact
602-952-0002
[email protected]
Timothy Byrne, DO
Principal Investigator
Tucson Medical Center
Tucson Arizona, 85712, United States More Info
Natalia Elias Calles, MPH
Contact
520-324-5512
[email protected]
Thomas E. Waggoner, DO
Principal Investigator
Baptist Health Heart Failure & Transplant Institute
Little Rock Arkansas, 72205, United States More Info
Amy Ford-Bland
Contact
[email protected]
Patrick Campbell, MD
Principal Investigator
University of California San Diego
La Jolla California, 92037, United States More Info
Maylene Alegre
Contact
858-246-2511
[email protected]
Jorge Silva Enciso, MD
Principal Investigator
Scripps Health
La Jolla California, 92121, United States More Info
John Gil-Flamer
Contact
[email protected]
Matthew Price, MD
Principal Investigator
University of Southern California
Los Angeles California, 90033, United States More Info
Melissa Ramos
Contact
818-309-5542
[email protected]
Ajay Vaidya, MD
Principal Investigator
Kaiser Permanente San Francisco
San Francisco California, 94115, United States More Info
Quyen Chau
Contact
415-833-3468
[email protected]
Van Selby, MD
Principal Investigator
University of California, San Francisco
San Francisco California, 94143, United States More Info
Jacqueline Furrier
Contact
415-476-4922
[email protected]
Liviu Klein, MD
Principal Investigator
University of Colorado
Aurora Colorado, 80045, United States
Hartford Health
Hartford Connecticut, 06102, United States More Info
William Roman
Contact
860-972-1558
[email protected]
Bryan Piccirillo, MD
Principal Investigator
Yale University
New Haven Connecticut, 06519, United States More Info
Linda Levesque, RN
Contact
203-737-6483
[email protected]
Lavanya Bellumkonda, MD
Principal Investigator
Medstar Health Research Institute
Washington District of Columbia, 20010, United States More Info
Megan Curl
Contact
[email protected]
Miguel Pinilla-Vera, MD
Principal Investigator
JFK Medical Center
Atlantis Florida, 33462, United States More Info
Abigail Bengco-Catalano
Contact
[email protected]
Waqas Ghumman, MD
Principal Investigator
HCA Florida Largo Hospital
Largo Florida, 33770, United States More Info
Holly-Lynn Grospitch
Contact
[email protected]
Saurabh Sanon, MD
Principal Investigator
University of Miami
Miami Florida, 33136, United States More Info
Barbara Lang
Contact
305-298-4471
[email protected]
Mrudula Munagala, MD
Principal Investigator
Ascension Sacred Heart
Pensacola Florida, 32504, United States More Info
Ashley Corlies
Contact
Rohit Amin, MD
Principal Investigator
University of South Florida
Tampa Florida, 33606, United States More Info
Mia Eifrid
Contact
[email protected]
Fadi Matar, MD
Principal Investigator
Emory University
Atlanta Georgia, 30308, United States More Info
Kristy Pitts
Contact
404-686-5775
[email protected]
Kendra Grubb, MD
Principal Investigator
Piedmont Heart Institute
Atlanta Georgia, 30309, United States
Northside Hospital
Atlanta Georgia, 30342, United States More Info
Kathleen Sutter
Contact
[email protected]
Mehrdad Toosi, MD
Principal Investigator
Northwestern University
Chicago Illinois, 60611, United States More Info
Meredith Chappell
Contact
312-926-7312
[email protected]
James Flaherty, MD
Principal Investigator
University of Chicago Medical Center
Chicago Illinois, 60637, United States More Info
Veronica Herzog
Contact
[email protected]
Gene Kim, MD
Principal Investigator
Advocate Good Samaritan Hospital
Downers Grove Illinois, 60515, United States More Info
Dominick Bufalino, MD
Principal Investigator
Cardiovascular Research Institute of Kansas
Wichita Kansas, 67226, United States More Info
Meredith Thunberg
Contact
[email protected]
Bassem Chehab, MD
Principal Investigator
Norton Heart Specialists
Louisville Kentucky, 40216, United States More Info
Tina Abell
Contact
[email protected]
Kelly McCants, MD
Principal Investigator
Our Lady of the Lake Regional Medical Center
Baton Rouge Louisiana, 70808, United States More Info
Micah Klumpp, Ph.D
Contact
225-526-0430
[email protected]
Jorge Castellanos, MD
Principal Investigator
Cardiovascular Institute of the South
Houma Louisiana, 70360, United States More Info
Deanna Benoit, LPN, CCRC
Contact
985-873-5613
[email protected]
Jennifer Aucoin, LPN, CCRC
Contact
985-873-5037
[email protected]
Peter Fail, MD
Principal Investigator
Northern Light Eastern Maine Medical Center
Bangor Maine, 04401, United States More Info
Christa Balmas
Contact
[email protected]
Matthew McKay, MD
Principal Investigator
University of Maryland Medical Center
Baltimore Maryland, 21201, United States More Info
Albert J Hicks, III, MD, MPH
Principal Investigator
Massachusetts General Hospital
Boston Massachusetts, 02114, United States More Info
Lina Fu
Contact
[email protected]
Ignacio Inglessis-Azuaje, MD
Principal Investigator
Beth Israel Deaconess Medical Center
Boston Massachusetts, 02215, United States More Info
Patricia Tyler, MSRN, FNP-c
Contact
617-632-7727
[email protected]
Jenifer Kaufman, RN, MS
Contact
617-632-8956
[email protected]
Arthur Rashad Garan, MD
Principal Investigator
University of Massachusetts
Worcester Massachusetts, 01655, United States More Info
Jenna Nickerson
Contact
[email protected]
Nikolaos Kakouros, MD
Principal Investigator
University of Michigan
Ann Arbor Michigan, 48109, United States More Info
Allison Schley
Contact
[email protected]
Abbas Bitar, MD
Principal Investigator
Spectrum Health
Grand Rapids Michigan, 49503, United States More Info
Elizabeth Helm
Contact
616-486-2080
[email protected]
Sangjin Lee, MD
Principal Investigator
William Beaumont Hospital
Royal Oak Michigan, 48073, United States More Info
Diedre Brunk
Contact
[email protected]
Ivan Hanson, MD
Principal Investigator
Ascension Providence Hospital
Southfield Michigan, 48075, United States More Info
Yulia Abidov
Contact
[email protected]
Shukri David, MD
Principal Investigator
Metropolitan Heart and Vascular Institute & Mercy Hosp
Coon Rapids Minnesota, 55433, United States More Info
Derek Vang
Contact
763-236-9347
[email protected]
Todd Drexel, MD
Principal Investigator
Minneapolis Heart Institute Foundation
Minneapolis Minnesota, 55407, United States More Info
Kari Thomas
Contact
[email protected]
Peter Eckman, MD
Principal Investigator
University of Minnesota
Minneapolis Minnesota, 55414, United States More Info
Julie Longman
Contact
[email protected]
Gregory Helmer, MD
Principal Investigator
Jackson Heart Clinic
Jackson Mississippi, 39216, United States More Info
Sandy Puckett
Contact
[email protected]
William Crowder, MD
Principal Investigator
Washington University in St. Louis
Saint Louis Missouri, 63110, United States More Info
Anne Dirks
Contact
314-454-8711
[email protected]
Justin Vader, MD
Principal Investigator
Deborah Heart & Lung
Browns Mills New Jersey, 08015, United States More Info
Andrew McElvarr
Contact
[email protected]
Richard Kovach, MD
Principal Investigator
Hackensack University Medical Center
Hackensack New Jersey, 07601, United States More Info
Manuel Castillo
Contact
[email protected]
Ryan Kaple, MD
Principal Investigator
Morristown Medical Center
Morristown New Jersey, 07960, United States
Montefiore Medical Center
Bronx New York, 10467, United States More Info
Nadia Persaud
Contact
[email protected]
Yogita Rochlani, MD
Principal Investigator
University at Buffalo
Buffalo New York, 14203, United States More Info
Elizabeth Hejna
Contact
[email protected]
Vijay Iyer, MD
Principal Investigator
Northwell Health
Manhasset New York, 11030, United States More Info
Gabriel Ragusa
Contact
[email protected]
Gerin Stevens, MD
Principal Investigator
NYU Langone Health
New York New York, 10016, United States More Info
Patricia Kozikowski
Contact
646-656-8510
[email protected]
Mydalyn Beronilla
Contact
[email protected]
Michael DiVita, MD
Principal Investigator
Mount Sinai Hospital
New York New York, 10029, United States More Info
Betsy Ellsworth, MSN, ANP
Contact
212-824-8902
[email protected]
Vivek Reddy, MD
Principal Investigator
CUMC/New York Presbyterian Hospital
New York New York, 10032, United States More Info
Kate Dalton
Contact
212-342-1820
[email protected]
Gabriel Sayer, MD
Principal Investigator
Weill Cornell Medicine-New York Presbyterian Hospital
New York New York, 10065, United States More Info
Dolores Reynolds
Contact
212-746-4617
[email protected]
Mark Reisman, MD
Principal Investigator
Vassar Brothers Medical Center
Poughkeepsie New York, 12601, United States More Info
William Rausch
Contact
845-483-6323
[email protected]
Rajeev Narayan, MD
Principal Investigator
St. Francis Hospital
Roslyn New York, 11576, United States More Info
Patricia Krug, MA, RN CCRC
Contact
516-562-6722
[email protected]
Elizabeth Haag, RN, MPA, CCRP
Contact
516-662-4512
[email protected]
George Petrossian, MD
Principal Investigator
NC Heart and Vascular Research, LLC
Raleigh North Carolina, 27607, United States More Info
Tiffany Johnson
Contact
919-784-4031
[email protected]
Robert Lee Jobe, MD
Principal Investigator
The Christ Hospital
Cincinnati Ohio, 45219, United States More Info
Denise Krabbe
Contact
513-585-1777
[email protected]
Dean Kereiakes, MD
Principal Investigator
UH Cleveland Medical Center
Cleveland Ohio, 44106, United States
Cleveland Clinic
Cleveland Ohio, 44195, United States More Info
Aliyah Tift
Contact
[email protected]
Rishi Puri, MD PhD FRACP
Principal Investigator
Ohio State University
Columbus Ohio, 43210, United States More Info
Alexa Coressel
Contact
614-247-7133
[email protected]
Konstantinos D Boudoulas, MD
Principal Investigator
INTEGRIS Baptist Medical Center
Oklahoma City Oklahoma, 73112, United States More Info
Dellia Dion
Contact
[email protected]
Douglas Horstmanshof, MD
Principal Investigator
Oklahoma Heart Hospital
Oklahoma City Oklahoma, 73120, United States More Info
Stacie Hanes, APRN-CNS, CCRN, CCRC
Contact
405-608-1283
[email protected]
Donna Grossman, RN, CCRC
Contact
405-608-1272
[email protected]
Mohammad Ghani, MD
Principal Investigator
Oklahoma Heart Institute
Tulsa Oklahoma, 74104, United States More Info
Lynette Tramell
Contact
[email protected]
Kamran Muhammad, MD
Principal Investigator
Providence St. Vincent Medical Center
Portland Oregon, 97225, United States More Info
Sarah Jackson
Contact
[email protected]
Jacob Abraham, MD
Principal Investigator
Oregon Health & Science University
Portland Oregon, 97239, United States More Info
John Halvorson
Contact
503-418-1679
[email protected]
Johannes Steiner, MD
Principal Investigator
Geisinger Clinic
Danville Pennsylvania, 17822, United States More Info
Susan Kilbride
Contact
570-271-8492
[email protected]
Shikhar Agarwal, MD
Principal Investigator
Pinnacle Health Cardiovascular Institute
Harrisburg Pennsylvania, 17101, United States
Penn State Hershey Medical Center
Hershey Pennsylvania, 17033, United States More Info
Katie Loffredo
Contact
[email protected]
John Boehmer, MD
Principal Investigator
Thomas Jefferson University
Philadelphia Pennsylvania, 19107, United States More Info
McKenna Krall
Contact
[email protected]
Nicholas Ruggiero, MD
Principal Investigator
Allegheny General Hospital
Pittsburgh Pennsylvania, 15212, United States More Info
Matthew Yeager
Contact
412-359-8468
[email protected]
Manreet Kanwar, MD
Principal Investigator
UPMC Heart and Vascular Institute
Pittsburgh Pennsylvania, 15232, United States More Info
Melissa Enlow
Contact
412-647-1582
[email protected]
Catalin Toma, MD
Principal Investigator
Rhode Island Hospital
Providence Rhode Island, 02904, United States More Info
Lori-Ann Desimone
Contact
[email protected]
Paul Gordon, MD
Principal Investigator
Medical University of South Carolina
Charleston South Carolina, 29425, United States More Info
Chandler Schwede
Contact
[email protected]
Daniel Steinberg, MD
Principal Investigator
Prisma Health
Columbia South Carolina, 29203, United States More Info
Amy Wolfe
Contact
[email protected]
Patrick McCann, MD
Principal Investigator
Tennova Healthcare-Turkey Creek Medical Center
Knoxville Tennessee, 37934, United States More Info
Beth Polk
Contact
[email protected]
Malcolm T Foster, III, MD
Principal Investigator
Ascension Saint Thomas
Nashville Tennessee, 37221, United States More Info
Amelia Drennan
Contact
[email protected]
Don Chomsky, MD
Principal Investigator
Vanderbilt University Medical Center
Nashville Tennessee, 87232, United States More Info
Sherry Bowman
Contact
615-936-0061
[email protected]
Colin Barker, MD
Principal Investigator
Ascension Texas Cardiovascular
Austin Texas, 78705, United States More Info
Ernest Haeusslein, MD
Principal Investigator
Austin Heart
Austin Texas, 78756, United States More Info
Amanda Carpenter, RN
Contact
512-206-3603
[email protected]
Juhana Karha, MD
Principal Investigator
Baylor Scott & White Research Institute
Dallas Texas, 75226, United States More Info
Susan Aston
Contact
214-820-7358
[email protected]
Yashasvi Chugh, MD
Principal Investigator
Houston Heart
Houston Texas, 77004, United States More Info
Joan Morrison
Contact
832-633-5463
[email protected]
Pranav Loyalka, MD
Principal Investigator
Baylor College of Medicine St. Luke's Medical Center
Houston Texas, 77020, United States More Info
Rachel Kronman-Gross
Contact
713-798-6230
[email protected]
Ajith Nair, MD
Principal Investigator
Houston Methodist Hospital
Houston Texas, 77030, United States More Info
LaShawna Green
Contact
713-441-6548
[email protected]
UT Health
Houston Texas, 77030, United States More Info
Chandni Patel
Contact
[email protected]
Marwan Jumean, MD
Principal Investigator
Texas Tech University Health Sciences Center
Lubbock Texas, 79430, United States More Info
Theresa Condez
Contact
806-470-0913
[email protected]
Mohammad (Mac) Ansari, MD
Principal Investigator
Baylor Scott & White
Plano Texas, 75093, United States
Methodist Healthcare System, San Antonio
San Antonio Texas, 78229, United States More Info
Maurene Cantu, RN
Contact
210-575-7863
[email protected]
Jorge Alvarez, MD
Principal Investigator
Intermountain Medical Center
Salt Lake City Utah, 84109, United States More Info
Riley Hodgson
Contact
801-507-4798
[email protected]
Brian Whisenant, MD
Principal Investigator
University of Virginia Health System
Charlottesville Virginia, 22908, United States More Info
Antonia Rupert
Contact
[email protected]
Mohammad Abuannadi, MD
Principal Investigator
Sentara Norfolk General Hospital
Norfolk Virginia, 23507, United States More Info
Ashley Williams
Contact
[email protected]
Amit Badiye, MD
Principal Investigator
CJW Chippenham Medical Center
Richmond Virginia, 23225, United States More Info
Stephanie Burton
Contact
804-852-2747
[email protected]
James Garnett, MD
Principal Investigator
Carilion Roanoke Memorial Hospital
Roanoke Virginia, 24014, United States More Info
Christina Bryant
Contact
540-853-0364
[email protected]
Jason Foerst, MD
Principal Investigator
Valley Health Winchester
Winchester Virginia, 22601, United States More Info
Rebekah Smith, RN, BSN
Contact
540-536-5547
[email protected]
Jason Call, MD
Principal Investigator
University of Washington
Seattle Washington, 98195, United States More Info
Jennifer Schaeffer
Contact
206-221-9154
[email protected]
Christine Chung, MD
Principal Investigator
Providence Sacred Heart Medical Center
Spokane Washington, 99204, United States More Info
Nicole McConnell
Contact
509-474-4308
[email protected]
James Mudd, MD
Principal Investigator
Charleston Area Medical Center
Charleston West Virginia, 25304, United States More Info
Kristi Sutphin
Contact
[email protected]
Richard Han, MD
Principal Investigator
Aurora St. Luke's Medical Center
Milwaukee Wisconsin, 53215, United States More Info
Donald Lobacz
Contact
414-649-3438
[email protected]
Suhail Allaqaband, MD
Principal Investigator
Medical College of Wisconsin
Milwaukee Wisconsin, 53226, United States More Info
Barbara Shimada-Krouwer, RN
Contact
[email protected]
Saif Anwaruddin, MD
Principal Investigator
Republican Scientific and Practical Centre of Cardiology
Minsk , 22003, Belarus More Info
Olesya Shatova, MD
Contact
[email protected]
Prof. Alena Kurlianskaya, MD, PhD
Principal Investigator
OLV Heart Centre
Aalst , 9300, Belgium More Info
Kathy De Knijf
Contact
053/72 44 49
[email protected]
Jozef Bartunek, MD, PhD
Principal Investigator
AZ Sint-Jan-Oostende AV Campus Brugge
Brugge , , Belgium More Info
Katrien Derycker
Contact
[email protected]
Jan Van Der Heijden, MD, PhD
Principal Investigator
St. Anne's University Hospital
Brno , 60200, Czechia More Info
Ota Hlinomaz, MD
Principal Investigator
Na Homolce Hospital
Prague , , Czechia More Info
Petr Moučka
Contact
420 257 272 392
[email protected]
Prof. Petr Neužil, MD, CSc, FESC
Principal Investigator
Hôpital de la Timone
Marseille , 13005, France More Info
Thomas Cuisset, MCU-PH, MD, PhD
Principal Investigator
CHU de Rennes - Hôpital Pontchaillou
Rennes , 35033, France More Info
Guillaume Leurent, MD
Principal Investigator
Clinique-Pasteur
Toulouse , 31300, France More Info
Nicolas Dumonteil, MD
Principal Investigator
St. Antonius Ziekenhuis
Nieuwegein , , Netherlands More Info
Conny Feirabend
Contact
31 (0)88 320 0900
[email protected]
Benno Rensing, MD
Principal Investigator
Erasmus Medical Center
Rotterdam , , Netherlands More Info
Elco van der Heide
Contact
010 703 2700
[email protected]
Nicolas Van Mieghem, MD, PhD
Principal Investigator
Institute of Cardiovascular Diseases of Vojvodina
Belgrade , 11000, Serbia More Info
Teodora Pantic, MD
Contact
Prof. Milovan Petrović
Principal Investigator
Institute of Cardiovascular Diseases
Belgrade , 11000, Serbia More Info
Una Radak, MD
Contact
Dragana Košević, MD
Principal Investigator
University Clinical Centre of Serbia
Belgrade , 11000, Serbia More Info
Prof. Arsen Ristić, MD, PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

400

Study ID:

NCT04331769

Recruitment Status:

Recruiting

Sponsor:


Ancora Heart, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.